(Q38770724)

English

Correlation between PD-L1 expression and outcome of NSCLC patients treated with anti-PD-1/PD-L1 agents: A meta-analysis

scientific article published on 6 March 2016

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6 September 2017

0 references

Correlation between PD-L1 expression and outcome of NSCLC patients treated with anti-PD-1/PD-L1 agents: A meta-analysis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26969107

retrieved

6 September 2017

main subject

non-small-cell lung carcinoma

1 reference

1 reference

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26969107

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969107%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 June 2020

author name string

Omar Abdel-Rahman

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26969107

retrieved

6 September 2017

publication date

6 March 2016

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26969107

retrieved

6 September 2017

published in

Critical Reviews in Oncology Hematology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26969107

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969107%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 June 2020

volume

101

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26969107

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969107%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 June 2020

page(s)

75-85

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26969107

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969107%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 June 2020

cites work

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.7326/0003-4819-151-4-200908180-00135

Identifiers

DOI

10.1016/J.CRITREVONC.2016.03.007

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26969107

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969107%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 June 2020

PubMed publication ID

26969107

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26969107

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969107%20AND%20SRC:MED&resulttype=core&format=json

(Q38770724)

Correlation between PD-L1 expression and outcome of NSCLC patients treated with anti-PD-1/PD-L1 agents: A meta-analysis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)